These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8738454)

  • 41. Possible colchicine rhabdomyolysis in a fluvastatin-treated patient.
    Atasoyu EM; Evrenkaya TR; Solmazgul E
    Ann Pharmacother; 2005; 39(7-8):1368-9. PubMed ID: 15956236
    [No Abstract]   [Full Text] [Related]  

  • 42. Colchicine in clinical medicine. A guide for internists.
    Cocco G; Chu DC; Pandolfi S
    Eur J Intern Med; 2010 Dec; 21(6):503-8. PubMed ID: 21111934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of gout in a renal transplant patient leading to severe thrombocytopenia.
    Weiler S; Aellig N; Fauchère I; Jetter A; Corti N
    J Clin Pharm Ther; 2014 Oct; 39(5):571-2. PubMed ID: 25040676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In older adults, new use of allopurinol or febuxostat was linked to hypersensitivity reactions versus colchicine.
    Schattner A
    Ann Intern Med; 2020 Jul; 173(2):JC10. PubMed ID: 32687746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colchicine in acute gout: optimal dose of colchicine is still elusive.
    Cox AR
    BMJ; 2004 Jan; 328(7434):288; author reply 289. PubMed ID: 14751912
    [No Abstract]   [Full Text] [Related]  

  • 46. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of occupational gout.
    Conway R; Carey JJ; Coughlan RJ
    Ir Med J; 2011; 104(10):316-7. PubMed ID: 22256449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of intravenous colchicine for podagra.
    Guazzo E
    Am Fam Physician; 1999 Dec; 60(9):2504, 2507. PubMed ID: 10605985
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of inpatients with adverse drug reactions to allopurinol.
    Khoo BP; Leow YH
    Singapore Med J; 2000 Apr; 41(4):156-60. PubMed ID: 11063179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allopurinol hypersensitivity syndrome.
    Anderson BE; Adams DR
    J Drugs Dermatol; 2002 Jul; 1(1):60-2. PubMed ID: 12847756
    [No Abstract]   [Full Text] [Related]  

  • 52. A caveat in the management of acute gout.
    Varughese GI; Varghese AI; Tahrani AA
    Am J Med; 2007 Nov; 120(11):e31; author reply e33. PubMed ID: 17976406
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of asymptomatic hyperuricemia].
    Floege J
    Internist (Berl); 1997 Dec; 38(12):1233. PubMed ID: 9465329
    [No Abstract]   [Full Text] [Related]  

  • 54. On call. I am a 72-year-old man with gout. I was getting three or four painful attacks every year until my doctor put me on Zyloprim. The medicine has been great--I haven't had an attack in more than two years. But I developed a bad rash and had to give up my Zyloprim. What can I do now?
    Simon HB
    Harv Mens Health Watch; 2004 Jun; 8(11):8. PubMed ID: 15210420
    [No Abstract]   [Full Text] [Related]  

  • 55. Death and morbidity from supratherapeutic dosing of colchicine.
    Sweidan M; Reeve JF; Yu K
    Med J Aust; 2011 Nov; 195(9):517. PubMed ID: 22060083
    [No Abstract]   [Full Text] [Related]  

  • 56. The Janus faces of allopurinol-allopurinol hypersensitivity syndrome.
    Tausche AK; Aringer M; Schroeder HE; Bornstein SR; Wunderlich C; Wozel G
    Am J Med; 2008 Mar; 121(3):e3-4. PubMed ID: 18328291
    [No Abstract]   [Full Text] [Related]  

  • 57. Hazards of colchicine.
    Jones WN; Maricic MJ
    Am J Health Syst Pharm; 2005 Jul; 62(13):1350; author reply 1350. PubMed ID: 15972374
    [No Abstract]   [Full Text] [Related]  

  • 58. Promoting the safe use of intravenous colchicine.
    Tortorici MA; Skledar S; Barnes B; Wasko MC
    Am J Health Syst Pharm; 2004 Dec; 61(23):2496, 2501. PubMed ID: 15595222
    [No Abstract]   [Full Text] [Related]  

  • 59. [Colchicine].
    Ben Slama L; Djemil M
    Rev Stomatol Chir Maxillofac; 2002 Apr; 103(2):128-9. PubMed ID: 11997742
    [No Abstract]   [Full Text] [Related]  

  • 60. Allopurinol-induced DRESS syndrome.
    Markel A
    Isr Med Assoc J; 2005 Oct; 7(10):656-60. PubMed ID: 16259349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.